XTL Biopharmaceuticals Reports Third Quarter 2017 Financial Results

Go back to XTL Biopharmaceuticals Reports Third Quarter 2017 Financial Results
XTL BIOPHARM SP ADR (NASDAQ: XTLB) Delayed: 2.60 --0 (-0%)
Previous Close $2.60    52 Week High $1.75 
Open $2.60    52 Week Low $0.64 
Day High $2.60    P/E N/A 
Day Low $2.60    EPS $0.00 
Volume      

XTL BIOPHARM SP ADR (NASDAQ: XTLB) Delayed: 2.60 --0 (-0%)
Previous Close $2.60    52 Week High $1.75 
Open $2.60    52 Week Low $0.64 
Day High $2.60    P/E N/A 
Day Low $2.60    EPS $0.00 
Volume